10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Microglia are the CNS resident immune cells that react to misfolded proteins through pattern recognition receptor ligation and activation of inflammatory pathways. Here, we studied how microglia handle and cope with α-synuclein (α-syn) fibrils and their clearance. We found that microglia exposed to α-syn establish a cellular network through the formation of F-actin-dependent intercellular connections, which transfer α-syn from overloaded microglia to neighboring naive microglia where the α-syn cargo got rapidly and effectively degraded. Lowering the α-syn burden attenuated the inflammatory profile of microglia and improved their survival. This degradation strategy was compromised in cells carrying the LRRK2 G2019S mutation. We confirmed the intercellular transfer of α-syn assemblies in microglia using organotypic slice cultures, 2-photon microscopy, and neuropathology of patients. Together, these data identify a mechanism by which microglia create an “on-demand” functional network in order to improve pathogenic α-syn clearance.

          Graphical abstract

          Highlights

          • Microglia rapidly engulf exogenous α-synuclein but hesitate in its degradation

          • α-synuclein is transferred between microglia through tunneling nanotubes

          • Healthy microglia donate mitochondria to α-synuclein overloaded cells

          • Sharing the α-synuclein burden attenuated the inflammatory microglia profile

          Abstract

          Microglia form F-actin dependent intercellular networks to transfer α-synuclein fibrils to neighboring microglial cells for degradation and clearance. Impairment in this process, as seen with Parkinson’s disease mutations, leads to increased inflammatory profiles and cell death.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: not found
          • Article: not found

          Alpha-synuclein in Lewy bodies.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Microglia Function in the Central Nervous System During Health and Neurodegeneration.

            Microglia are resident cells of the brain that regulate brain development, maintenance of neuronal networks, and injury repair. Microglia serve as brain macrophages but are distinct from other tissue macrophages owing to their unique homeostatic phenotype and tight regulation by the central nervous system (CNS) microenvironment. They are responsible for the elimination of microbes, dead cells, redundant synapses, protein aggregates, and other particulate and soluble antigens that may endanger the CNS. Furthermore, as the primary source of proinflammatory cytokines, microglia are pivotal mediators of neuroinflammation and can induce or modulate a broad spectrum of cellular responses. Alterations in microglia functionality are implicated in brain development and aging, as well as in neurodegeneration. Recent observations about microglia ontogeny combined with extensive gene expression profiling and novel tools to study microglia biology have allowed us to characterize the spectrum of microglial phenotypes during development, homeostasis, and disease. In this article, we review recent advances in our understanding of the biology of microglia, their contribution to homeostasis, and their involvement in neurodegeneration. Moreover, we highlight the complexity of targeting microglia for therapeutic intervention in neurodegenerative diseases. Expected final online publication date for the Annual Review of Immunology Volume 35 is April 26, 2017. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              INTERFEROME v2.0: an updated database of annotated interferon-regulated genes

              Interferome v2.0 (http://interferome.its.monash.edu.au/interferome/) is an update of an earlier version of the Interferome DB published in the 2009 NAR database edition. Vastly improved computational infrastructure now enables more complex and faster queries, and supports more data sets from types I, II and III interferon (IFN)-treated cells, mice or humans. Quantitative, MIAME compliant data are collected, subjected to thorough, standardized, quantitative and statistical analyses and then significant changes in gene expression are uploaded. Comprehensive manual collection of metadata in v2.0 allows flexible, detailed search capacity including the parameters: range of -fold change, IFN type, concentration and time, and cell/tissue type. There is no limit to the number of genes that can be used to search the database in a single query. Secondary analysis such as gene ontology, regulatory factors, chromosomal location or tissue expression plots of IFN-regulated genes (IRGs) can be performed in Interferome v2.0, or data can be downloaded in convenient text formats compatible with common secondary analysis programs. Given the importance of IFN to innate immune responses in infectious, inflammatory diseases and cancer, this upgrade of the Interferome to version 2.0 will facilitate the identification of gene signatures of importance in the pathogenesis of these diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell
                Cell
                Cell
                Cell Press
                0092-8674
                1097-4172
                30 September 2021
                30 September 2021
                : 184
                : 20
                : 5089-5106.e21
                Affiliations
                [1 ]Department of Neurodegenerative Disease and Geriatric Psychiatry/Neurology, University of Bonn Medical Center, 53127 Bonn, Germany
                [2 ]German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany
                [3 ]Institute of Innate Immunity, University of Bonn Medical Center, 53127 Bonn, Germany
                [4 ]Institut François Jacob, MIRCen, CEA and Laboratory of Neurodegenerative Diseases, CNRS, 92265 Fontenay-aux-Roses, France
                [5 ]Divison of Infectious Diseases and Immunology, University of Massachusetts Medical School, 01605 Worcester, MA, USA
                Author notes
                []Corresponding author michael.heneka@ 123456ukbonn.de
                [6]

                Lead contact: Michael T. Heneka

                Article
                S0092-8674(21)01054-0
                10.1016/j.cell.2021.09.007
                8527836
                34555357
                b047a1bb-19c8-40b6-b1d5-9a6bb9ce1841
                © 2021 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 20 July 2020
                : 5 June 2021
                : 3 September 2021
                Categories
                Article

                Cell biology
                microglia,alpha-synuclein,tunneling nanotubes,cell-to-cell transfer,clearance,lrrk2,synucleinopathies,degradation

                Comments

                Comment on this article